Whitehawk Therapeutics, Inc. (WHWK)
NASDAQ: WHWK · Real-Time Price · USD
1.965
+0.015 (0.77%)
Sep 18, 2025, 1:47 PM EDT - Market open
Whitehawk Therapeutics Market Cap
Whitehawk Therapeutics has a market cap or net worth of $92.61 million as of September 18, 2025. Its market cap has increased by 114.87% in one year.
Market Cap
92.61M
Enterprise Value
-84.20M
1-Year Change
114.87%
Ranking
Category
Stock Price
$1.97
Market Cap Chart
Since August 9, 2017, Whitehawk Therapeutics's market cap has decreased from $162.50M to $92.61M, a decrease of -43.01%. That is a compound annual growth rate of -6.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2025 | 91.90M | 18.12% |
| Dec 31, 2024 | 77.80M | 57.17% |
| Dec 29, 2023 | 49.50M | -84.19% |
| Dec 30, 2022 | 313.00M | -37.97% |
| Dec 31, 2021 | 504.60M | 992.21% |
| Dec 31, 2020 | 46.20M | 82.61% |
| Dec 31, 2019 | 25.30M | -63.33% |
| Dec 31, 2018 | 69.00M | -46.35% |
| Dec 29, 2017 | 128.60M | -20.86% |
| Aug 9, 2017 | 162.50M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 693.85B |
| Johnson & Johnson | 427.46B |
| AbbVie | 390.97B |
| UnitedHealth Group | 308.42B |
| Novo Nordisk | 253.09B |
| AstraZeneca | 240.11B |
| Novartis AG | 237.94B |
| Abbott Laboratories | 232.77B |